Journal articleEndocr J2018
Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
- Journal
- Endocr J
- Published
- 11 April 2018
- Citations
- 18
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer is a highly lethal malignancy. CA19-9 is a well-known marker for diagnosis of pancreatic cancer, but the serum CA19-9 level is reported to be elevated in patients with poorly controlled diabetes. … Excerpt only: this text is the publisher’s. Read it in full at the source.